Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Newly Diagnosed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01054144
What this trial is testing

Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 27
Large-scale testing (Phase 3)Active Not RecruitingNCT04483739
What this trial is testing

Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 302
Not applicableLooking for participantsNCT05259553
What this trial is testing

Biomarkers in Multiple Myeloma

Who this might be right for
Hematological PatientsNewly Diagnosed Multiple MyelomaChemotherapy
Centre Hospitalier Universitaire de Saint Etienne 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT03376672
What this trial is testing

Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

Who this might be right for
Multiple Myeloma
Raija Silvennoinen 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04891809
What this trial is testing

Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM

Who this might be right for
Newly Diagnosed Multiple Myeloma
Arbeitsgemeinschaft medikamentoese Tumortherapie 198
Large-scale testing (Phase 3)Ended earlyNCT01891643
What this trial is testing

PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Previously Untreated Multiple Myeloma (ELO 1 Substudy)

Who this might be right for
Newly Diagnosed, Previously Untreated Multiple Myeloma
Bristol-Myers Squibb 23
Testing effectiveness (Phase 2)Study completedNCT01559935
What this trial is testing

Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Weill Medical College of Cornell University 74
Not applicableStudy completedNCT03006315
What this trial is testing

Mobile Health Device Study for Myeloma Patients

Who this might be right for
Multiple MyelomaMyeloma
Memorial Sloan Kettering Cancer Center 40
Not applicableStudy completedNCT02439112
What this trial is testing

Exercise in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Zealand University Hospital 102
Large-scale testing (Phase 3)Study completedNCT02312258
What this trial is testing

Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT)

Who this might be right for
Multiple Myeloma
Takeda 706
Testing effectiveness (Phase 2)Ended earlyNCT01881789
What this trial is testing

Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 22
Not applicableUnknownNCT01671826
What this trial is testing

Autologous Stem Cell Transplantation for Myeloma Patients Over 65 Years

Who this might be right for
Newly Diagnosed Myeloma Patient Above 65 Years Old
Assistance Publique - Hôpitaux de Paris 55
Early research (Phase 1)Study completedNCT01980589
What this trial is testing

A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects

Who this might be right for
Multiple Myeloma
Amgen 22
Testing effectiveness (Phase 2)Looking for participantsNCT02343042
What this trial is testing

Selinexor and Backbone Treatments of Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Karyopharm Therapeutics Inc 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT04808037
What this trial is testing

Blmf, Lenalidomide and Dexamethasone in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hellenic Society of Hematology 66
Testing effectiveness (Phase 2)Study completedNCT01402284
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT03606577
What this trial is testing

An Intensive Program With Quadruplet Induction and Consolidation Plus Tandem Autologous Stem Cell Transplantation in Newly Diagnosed High Risk Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Nantes University Hospital 50
Testing effectiveness (Phase 2)Study completedNCT01370434
What this trial is testing

Two Cycles of PAD Combination by AHCT in MM

Who this might be right for
Multiple Myeloma
Cooperative Study Group A for Hematology 43
Testing effectiveness (Phase 2)Study completedNCT01698801
What this trial is testing

Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 26
Large-scale testing (Phase 3)Looking for participantsNCT05561387
What this trial is testing

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Who this might be right for
Plasma Cell Myeloma
SWOG Cancer Research Network 510
Next Page